GEN – Genetic Engineering and Biotechnology News

Register Now

Sam Zhang, PhD, has more than 18 years ...

A new Tufts Center for the Study of Drug Development (CSDD) analysis shows that an AI clinical monitoring agent can deliver net financial gains as high as $21 million per drug development program and 82 times the return on investment.

The findings are based on benchmarked oncology program and clinical trial data from Tufts CSDD and contract value data from Medable, whi...

Memories can survive even after the brain temporarily loses more than half of its synaptic connections, according to the results of a study in mice that challenge the long-held view that long-term memories depend on stable individual synapses. The researchers, headed by a team at Okinawa Institute of Science and Technology (OIST), and including teams at the University of Tsuk...

Antibody reagent variability is a leading but frequently underappreciated source of irreproducible preclinical data. For in vivo studies, th...

For most of modern medicine, we have treated disease as a static condition. A patient has cancer. A patient has rheumatoid arthritis. A patient has inflammatory bowel disease. Diagnosis has largely meant identifying the condition, assigning a label, and selecting a treatment based on the standard of care.

Bu...